NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69539-049-92 | 69539-049 | HUMAN PRESCRIPTION DRUG | Abiraterone | Abiraterone acetate | TABLET | ORAL | 20190710 | N/A | ANDA | ANDA210686 | MSN LABORATORIES PRIVATE LIMITED | ABIRATERONE ACETATE | 250 mg/1 | 120 TABLET in 1 BOTTLE (69539-049-92) |
72205-030-92 | 72205-030 | HUMAN PRESCRIPTION DRUG | Abiraterone | Abiraterone acetate | TABLET | ORAL | 20190710 | N/A | ANDA | ANDA210686 | Novadoz Pharmaceuticals LLC | ABIRATERONE ACETATE | 250 mg/1 | 120 TABLET in 1 BOTTLE (72205-030-92) |
68001-489-07 | 68001-489 | HUMAN PRESCRIPTION DRUG | Abiraterone | Abiraterone acetate | TABLET | ORAL | 20210226 | N/A | ANDA | ANDA210686 | BluePoint Laboratories | ABIRATERONE ACETATE | 250 mg/1 | 120 TABLET in 1 BOTTLE (68001-489-07) |